Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Genomics Market Worth 23.88 Billion USD by 2022

PUNE, India, October 6, 2017 /PRNewswire/ --

According to a new market research report "Genomics Market by Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) - Forecast to 2022", published by MarketsandMarketstm, the market is expected to reach USD 23.88 Billion by 2022 from an estimated USD 14.71 Billion in 2017, at a CAGR of 10.2%.

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

Browse 112 Market Data Tables and 43 Figures spread through 218 Pages and in-depth TOC on "Genomics Market"


Early buyers will receive 10% customization on this report 

The key factors such as growth in the number of R&D activities, growing demand for personalized medicine and reducing cost of sequencing services are driving the growth of this market.

By products and services, the consumables segment accounted for the largest share of the market in 2017 

On the basis of products and services, the Genomics Market has been segmented into instruments/systems, consumables and services. In 2017, the consumables segment is expected to account for the largest share of the global Genomics Market. The services segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. Growth in this segment is mainly driven by the increase in the biotechnology and genomics services start-ups, adoption of genetic testing by hospitals and decrease in the sequencing costs.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=613

By technology, the PCR technology accounted for the largest share of the market in 2017 

On the basis of technology, the Genomics Market has been segmented into sequencing, microarray, PCR, nucleic acid extraction and purification and other technologies such as genotyping and gene editing. In 2017, the PCR technology is expected to account for the largest share of the global Genomics Market. The sequencing technology, on the other hand, is expected to be the fastest-growing segment during the forecast period. Growth in this technology attributes to the increase in genomics application areas, and advancements in the sequencing technology such as high throughput sequencing.

By process, the sequencing segment accounted for the largest share of the market in 2017 

On the basis of process, the Genomics Market has been segmented into library preparation, sequencing and data analysis. In 2017, the sequencing is expected to account for the largest share of the global Genomics Market. It is also expected to be the fastest-growing segment during the forecast period. Growing adoption of genetic testing by hospitals and decreasing costs of sequencing services are expected to drive the growth of the segment.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=613

North America dominated the market in 2017 

North America accounted for the largest share of the Genomics Market in 2017, followed by Europe. The large share of the North American Genomics Market can be attributed to the growth in biotechnology and genomics research grants and funds in the US focus on precision medicine and pan-Canadian program.

The various players in the Genomics Market include F. Hoffmann-La Roche (Switzerland), Thermo Fisher Scientific (US), BGI (China), Illumina (US), QIAGEN (Netherlands), GE Healthcare (UK), Bio-Rad Laboratories (US), Eurofins Scientific (Germany), Agilent Technologies, (US), Oxford Nanopore Technologies (UK), Pacific Biosciences of California (US), and Eppendorf (Germany) among others.

Browse Related Reports 

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021

About MarketsandMarketstm  

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Rohan
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Visit Our Blog@ http://mnmblog.org/market-research/healthcare/biotechnology  

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

These press releases may also interest you

at 03:00
TAIPEI, Taiwan, Oct. 20, 2017 /PRNewswire/ -- Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClosetm, successfully closed...

at 03:00
DARMSTADT, Germany, Oct. 20, 2017 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its healthcare business in the U.S. and Canada as EMD Serono, today announced 11 abstracts are scheduled for...

at 02:45
ZURICH, October 20, 2017 /PRNewswire/ -- PWC Switzerland and MLL sell Automated Documents to the Public  PartnerVine, an online portal for the sale of automated legal documents, launched today in a beta version. With PricewaterhouseCoopers...

at 02:36
STOCKHOLM, Oct. 20, 2017 /PRNewswire/ --Third quarter Net sales increased by 3% to SEK 18,499 M (18,025), with organic growth of 3% (2) and acquired growth of 2% (2) Strong growth was shown by Global Technologies and good growth by EMEA, Americas,...

at 02:34
SHANGHAI, Oct. 20, 2017 /PRNewswire/ -- Many Chinese parents don't know how much damage headphones can cause to their children's hearing. When they chose an online English learning platform, they may not consider the damage of headphones. In fact,...

at 02:34
STOCKHOLM, Oct. 20, 2017 /PRNewswire/ -- Kai Wärn, President and CEO: "Net sales for the Group in the seasonally smaller third quarter continued to grow, increasing by 4% adjusted for currency. Operating income amounted to SEK 433m (431), including...

News published on 6 october 2017 at 06:30 and distributed by: